Related references
Note: Only part of the references are listed.Pharmacological potential of ginseng and its major component ginsenosides
Zubair Ahmed Ratan et al.
JOURNAL OF GINSENG RESEARCH (2021)
Reversible and Irreversible Inhibition of Cytochrome P450 Enzymes by Methylophiopogonanone A
Dong-Zhu Tu et al.
DRUG METABOLISM AND DISPOSITION (2021)
Development of 20(S)-Protopanaxadiol-Loaded SNEDDS Preconcentrate Using Comprehensive Phase Diagram for the Enhanced Dissolution and Oral Bioavailability
Young Hoon Kim et al.
PHARMACEUTICS (2020)
(-)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes
Marie-Lynn Cuypers et al.
DRUG METABOLISM AND DISPOSITION (2020)
Differential Effects of 1α,25-Dihydroxyvitamin D3 on the Expressions and Functions of Hepatic CYP and UGT Enzymes and Its Pharmacokinetic Consequences In Vivo
Trang Nguyen Kieu Doan et al.
PHARMACEUTICS (2020)
20(S)-protopanaxadiol induces apoptosis in human umbilical vein endothelial cells by activating the PERK-eIF2alpha-ATF4 signaling pathway
Xue Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
Zhu Wang et al.
CHINESE MEDICINE (2019)
Protopanaxadiol alleviates obesity in high-fat diet-fed mice via activation of energy-sensing neuron in the paraventricular nucleus of hypothalamus
Chuhe Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Natural occurring polysaccharides from Panax ginseng C. A. Meyer: A review of isolation, structures, and bioactivities
Bin Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D3: Effects on in vivo oral absorption and disposition of buspirone in rats
Han-Joo Maeng et al.
DRUG DEVELOPMENT RESEARCH (2019)
Inhibition of human carboxylesterases by ginsenosides: structure-activity relationships and inhibitory mechanism
Zhao-Hui Sun et al.
CHINESE MEDICINE (2019)
Characterization and structure-activity relationship studies of flavonoids as inhibitors against human carboxylesterase 2
Zi-Miao Weng et al.
BIOORGANIC CHEMISTRY (2018)
Anticancer effects of ginsenoside Rg3 (Review)
Mengyao Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases
Ji Hye Kim et al.
JOURNAL OF GINSENG RESEARCH (2017)
A nanoparticulate drug-delivery system for 20(S)-protopanaxadiol: formulation, characterization, increased oral bioavailability and anti-tumor efficacy
Meihua Han et al.
DRUG DELIVERY (2016)
Neuroprotective effects of 20(S)-protopanaxadiol against glutamate-induced mitochondrial dysfunction in PC12 cells
Dong-Ho Bak et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery
Chen Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Effects of Korean red ginseng (Panax ginseng) on obesity and adipose inflammation in ovariectomized mice
Hyunghee Lee et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
In vitro and in vivo anti-inflammatory activities of Korean Red Ginseng-derived components
Kwang-Soo Baek et al.
JOURNAL OF GINSENG RESEARCH (2016)
Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′ -OH-bupropion in vitro
Jennifer E. Sager et al.
DRUG METABOLISM AND DISPOSITION (2016)
Anti-fatigue Effects of 20(S)-Protopanaxadiol and 20(S)-Protopanaxatriol in Mice
Hyun A. Oh et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Protective Effects of Processed Ginseng and Its Active Ginsenosides on Cisplatin-Induced Nephrotoxicity: In Vitro and in Vivo Studies
Jun Yeon Park et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview
Alice S. T. Wong et al.
NATURAL PRODUCT REPORTS (2015)
Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its foUr bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition
Yu Fen Zheng et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Effects of ginsenosides on the expression of cytochrome P450s and transporters involved in cholesterol metabolism
Atsushi Kawase et al.
JOURNAL OF NATURAL MEDICINES (2014)
In vitro biotransformation of red ginseng extract by human intestinal microflora: Metabolites identification and metabolic profile elucidation using LC-Q-TOF/MS
Huai-You Wang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Increased effects of ginsenosides on the expression of cholesterol 7α-hydroxylase but not the bile salt export pump are involved in cholesterol metabolism
Atsushi Kawase et al.
JOURNAL OF NATURAL MEDICINES (2013)
Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways
Jian-Li Gao et al.
ONCOLOGY REPORTS (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs)
Zhong-Ze Fang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Determination of 20(S)-protopanaxadiol in human plasma by HPLC MS/MS: application to a pharmacokinetic study
Feifan Xie et al.
ACTA PHARMACEUTICA SINICA B (2013)
Herb-Drug Interactions and Mechanistic and Clinical Considerations
Xiao-Wu Chen et al.
CURRENT DRUG METABOLISM (2012)
Ginseng and Diabetes: The Evidences from In Vitro, Animal and Human Studies
Hai-Dan Yuan et al.
JOURNAL OF GINSENG RESEARCH (2012)
Identification of 20(S)-Protopanaxadiol Metabolites in Human Liver Microsomes and Human Hepatocytes
Liang Li et al.
DRUG METABOLISM AND DISPOSITION (2011)
Effects of Panax ginseng on Tumor Necrosis Factor-α-Mediated Inflammation: A Mini-Review
Davy C. W. Lee et al.
MOLECULES (2011)
Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells
Kar Wah Leung et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A!Meyer
Kwang-tae Choi
ACTA PHARMACOLOGICA SINICA (2008)
Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium
Chieh-fu Chen et al.
ACTA PHARMACOLOGICA SINICA (2008)
Intestinal first-pass metabolism of CYP3A4 substrates
Motohiro Kato
DRUG METABOLISM AND PHARMACOKINETICS (2008)
Comparison of Human Cytochrome P450 Inhibition by the Thienopyridines Prasugrel, Clopidogrel, and Ticlopidine
Katsunobu Hagihara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2008)
Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: Application of pharmacokinetic study in rats
Hong-can Ren et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Ginsenoside Rb1 reduces neurodegeneration in the peri-infarct area of a thromboembolic stroke model in non-human primates
Tetsuya Yoshikawa et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Measurements of rat and mouse gastrointestinal pH fluid and lymphoid tissue, and implications for in-vivo experiments
Emma L. McConnell et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2008)
Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome p450 3A4 and the role of therapeutic drug monitoring
Shu-Feng Zhou et al.
THERAPEUTIC DRUG MONITORING (2007)
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
Marcella Martignoni et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress
Sang Hee Lee et al.
PHARMACOLOGICAL RESEARCH (2006)
Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes
Yong Liu et al.
TOXICOLOGICAL SCIENCES (2006)
Influence of ginsenoside Rh1 and F1 on human cytochrome P450 enzymes
Y Liu et al.
PLANTA MEDICA (2006)
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects
S Rodriguez-Novoa et al.
CLINICAL INFECTIOUS DISEASES (2005)
Examination of 209 drugs for inhibition of cytochrome p450 2C8
RL Walsky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Incidence and severity of potential drug-dietary supplement interactions in primary care patients - An exploratory study of 2 outpatient practices
CC Peng et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate
K Radad et al.
BRAIN RESEARCH (2004)
Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine
T Richter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Validation of (-)-N-3-benzyl-phenobarbital as a selective inhibitor of CYP2C19 in human liver microsomes
XX Cai et al.
DRUG METABOLISM AND DISPOSITION (2004)
Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: Comparison with fluoxetine and quinidine
KM Bertelsen et al.
DRUG METABOLISM AND DISPOSITION (2003)
CYP2C19 genotype determines enzyme activity and inducibility of S-mephenytoin hydroxylase
HH Zhou
CLINICA CHIMICA ACTA (2001)
Share Paper
